Impact of a Glaucoma Awareness Program on Treatment Adherence

ConditionGlaucoma
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSeva Canada Society

About this trial

Glaucoma is a leading cause of irreversible blindness worldwide, with a higher burden in low- and middle-income countries such as Nepal, where public awareness and treatment adherence remain poor. Lifelong adherence to treatment is important to prevent disease progression but still non adherence remains common.

This is a mixed method study which aims to evaluate the effectiveness of structured glaucoma awareness program in improving treatment adherence among glaucoma patients attending a tertiary eye hospital in Nepal. Quantitative assessment will measure changes in treatment adherence using Medication Adherence Scale at baseline and three months post intervention. A qualitative component will explore participants' perceptions of glaucoma program and suggestions for improvement through semi-structured interviews.

Eligibility criteria

Qualifiers

Adults aged ≥18 years

Diagnosed with glaucoma

Attending follow-up at the study hospital

Able to provide informed consent

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Glaucoma awareness and patient education program

Treatment groups

60 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

Seva Canada Society

Lead sponsor

Reiyukai Eiko Masunaga Eye Hospital (REMEH)

Collaborator

Pragyaan Sustainable Health Outcomes Foundation

Collaborator